Primary record
(-)-N-(((R)-2,3-DIHYDROXYPROPYL)OXY)-3,4-DIFLUORO-2-((2-FLUORO-4-IODOPHENYL)AMINO)BENZAMIDE
- 库存
- 1,355 克
- 纯度
- 98.5 %
- CAS
- 391210-10-9
化合物标识与属性
- CAS
- 391210-10-9
- PubChem CID
- 9826528
- SMILES
- C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O
- Canonical SMILES
- O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
名称与同义词
- Mirdametinib
- 391210-10-9
- PD0325901
- PD 0325901
- GOMEKLI
- Ezmekly
- PD-0325901
- Mirdametinib [USAN]
- Ezmekly (TN)
- Gomekli (TN)
- Mirdametinib (GMP)
- Mirdametinib (USAN)
- PD-325901
- RefChem:818905
- 86K0J5AK6M
- GlyTouCan:G85685CG
- UNII-86K0J5AK6M
- C16H14F3IN2O4
- DTXSID0044024
- MIRDAMETINIB [INN]
- cc-61
- D0K0YC
- (R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
- CHEMBL507361
- SUDAHWBOROXANE-SECBINFHSA-N
- DTXCID8024024
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
- CHEBI:88249
- PD 325901
- Pd 901
- MIRDAMETINIB [WHO-DD]
- PD0325901(Mirdametinib)
- PD325901
- SCHEMBL172904
- MFCD08435926
- GTPL7935
- MEK Inhibitor PD0325901
- orb1300996
- PD0325901 (Mirdametinib)
- SCHEMBL29352748
- SCHEMBL29358470
- CTK8B5048
- EX-A102
- SYN1059
- PD-901
- BCPP000126
- BDBM104963
- GLXC-90133
- HMS3648A14
- AMY36437
- AOB87344
- G85685CG
- ZINC3938683
- Tox21_113364
- ABP000920
- AN-191
- ANW-47220
- EBC-11337
- HB2240
- HY-10254G
- NCGC00189075-01
- NSC755770
- NSC800840
- s1036
- WHO 11299
- (R)-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE
- AKOS015855518
- ACN-040174
- AN-5314
- BCP9001057
- CCG-221316
- CID9826528
- CS-0062
- DB07101
- EX-8602
- FP26781
- NSC-755770
- NSC-800840
- RTR-015696
- SDCCGSBI-0654263.P002
- CID:9826528
- KS-0000007I
- NCGC00381744-09
- AJ-47457
- BC245090
- BP-43620
- BR-78415
- HY-10254
- Pd 03525901
- PD-03525901
- SID:76715719
- US8575391, Q
- AB0007877
- TR-015696
- A3013
- A6561
- BB 0261791
- CAS-391210-10-9
- FT-0673534
- NS00069616
- PD-0235901
- ST24020764
- SW218101-2
- W5947
- J2.753.603D
- A10256
- D11675
- S-7112
- S06-0029
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
- PD-0325901,PD325901
- C506614
- PD 0325901, >=98% (HPLC)
- PD-0325901/PD0325901
- PD0325901, 98% - 10MG 10mg
- SR-01000946344
- 391209-97-5
- SR-01000946344-1
- BRD-K49865102-001-01-9
- BRD-K49865102-001-08-4
- I01-15945
- Q27088255
- B0084-091588
- Benzamide, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-
- N-[((R)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
- N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
- 870474-62-7
- Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-
- N-((2R)-2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide
- N-((R)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-anilino)benzamide
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide
- InSolution MEK1/2 Inhibitor III, PD0325901 - CAS 391210-10-9
- Benzamide,N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-
- N-((R)-2,3-Dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide
- N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide
- N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4iodophenyl)amino]-benzamide
- N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2[(2-fluoro-4-iodophenyl)amino]-benzamide
- N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide
- N-[(R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
- N-{[(2S)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
- (-)-N-(((R)-2,3-DIHYDROXYPROPYL)OXY)-3,4-DIFLUORO-2-((2-FLUORO-4-IODOPHENYL)AMINO)BENZAMIDE
- 4BM